1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Bioresorbable Drug-Eluting Stents Annual Sales 2020-2031 2.1.2 World Current & Future Analysis for Bioresorbable Drug-Eluting Stents by Geographic Region, 2020, 2024 & 2031 2.1.3 World Current & Future Analysis for Bioresorbable Drug-Eluting Stents by Country/Region, 2020, 2024 & 2031 2.2 Bioresorbable Drug-Eluting Stents Segment by Type 2.2.1 Metal Base Stent 2.2.2 Polymer Stent 2.3 Bioresorbable Drug-Eluting Stents Sales by Type 2.3.1 Global Bioresorbable Drug-Eluting Stents Sales Market Share by Type (2020-2025) 2.3.2 Global Bioresorbable Drug-Eluting Stents Revenue and Market Share by Type (2020-2025) 2.3.3 Global Bioresorbable Drug-Eluting Stents Sale Price by Type (2020-2025) 2.4 Bioresorbable Drug-Eluting Stents Segment by Application 2.4.1 Hospital 2.4.2 Specialty Clinic 2.5 Bioresorbable Drug-Eluting Stents Sales by Application 2.5.1 Global Bioresorbable Drug-Eluting Stents Sale Market Share by Application (2020-2025) 2.5.2 Global Bioresorbable Drug-Eluting Stents Revenue and Market Share by Application (2020-2025) 2.5.3 Global Bioresorbable Drug-Eluting Stents Sale Price by Application (2020-2025) 3 Global by Company 3.1 Global Bioresorbable Drug-Eluting Stents Breakdown Data by Company 3.1.1 Global Bioresorbable Drug-Eluting Stents Annual Sales by Company (2020-2025) 3.1.2 Global Bioresorbable Drug-Eluting Stents Sales Market Share by Company (2020-2025) 3.2 Global Bioresorbable Drug-Eluting Stents Annual Revenue by Company (2020-2025) 3.2.1 Global Bioresorbable Drug-Eluting Stents Revenue by Company (2020-2025) 3.2.2 Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Company (2020-2025) 3.3 Global Bioresorbable Drug-Eluting Stents Sale Price by Company 3.4 Key Manufacturers Bioresorbable Drug-Eluting Stents Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Bioresorbable Drug-Eluting Stents Product Location Distribution 3.4.2 Players Bioresorbable Drug-Eluting Stents Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Bioresorbable Drug-Eluting Stents by Geographic Region 4.1 World Historic Bioresorbable Drug-Eluting Stents Market Size by Geographic Region (2020-2025) 4.1.1 Global Bioresorbable Drug-Eluting Stents Annual Sales by Geographic Region (2020-2025) 4.1.2 Global Bioresorbable Drug-Eluting Stents Annual Revenue by Geographic Region (2020-2025) 4.2 World Historic Bioresorbable Drug-Eluting Stents Market Size by Country/Region (2020-2025) 4.2.1 Global Bioresorbable Drug-Eluting Stents Annual Sales by Country/Region (2020-2025) 4.2.2 Global Bioresorbable Drug-Eluting Stents Annual Revenue by Country/Region (2020-2025) 4.3 Americas Bioresorbable Drug-Eluting Stents Sales Growth 4.4 APAC Bioresorbable Drug-Eluting Stents Sales Growth 4.5 Europe Bioresorbable Drug-Eluting Stents Sales Growth 4.6 Middle East & Africa Bioresorbable Drug-Eluting Stents Sales Growth 5 Americas 5.1 Americas Bioresorbable Drug-Eluting Stents Sales by Country 5.1.1 Americas Bioresorbable Drug-Eluting Stents Sales by Country (2020-2025) 5.1.2 Americas Bioresorbable Drug-Eluting Stents Revenue by Country (2020-2025) 5.2 Americas Bioresorbable Drug-Eluting Stents Sales by Type (2020-2025) 5.3 Americas Bioresorbable Drug-Eluting Stents Sales by Application (2020-2025) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Bioresorbable Drug-Eluting Stents Sales by Region 6.1.1 APAC Bioresorbable Drug-Eluting Stents Sales by Region (2020-2025) 6.1.2 APAC Bioresorbable Drug-Eluting Stents Revenue by Region (2020-2025) 6.2 APAC Bioresorbable Drug-Eluting Stents Sales by Type (2020-2025) 6.3 APAC Bioresorbable Drug-Eluting Stents Sales by Application (2020-2025) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Bioresorbable Drug-Eluting Stents by Country 7.1.1 Europe Bioresorbable Drug-Eluting Stents Sales by Country (2020-2025) 7.1.2 Europe Bioresorbable Drug-Eluting Stents Revenue by Country (2020-2025) 7.2 Europe Bioresorbable Drug-Eluting Stents Sales by Type (2020-2025) 7.3 Europe Bioresorbable Drug-Eluting Stents Sales by Application (2020-2025) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Bioresorbable Drug-Eluting Stents by Country 8.1.1 Middle East & Africa Bioresorbable Drug-Eluting Stents Sales by Country (2020-2025) 8.1.2 Middle East & Africa Bioresorbable Drug-Eluting Stents Revenue by Country (2020-2025) 8.2 Middle East & Africa Bioresorbable Drug-Eluting Stents Sales by Type (2020-2025) 8.3 Middle East & Africa Bioresorbable Drug-Eluting Stents Sales by Application (2020-2025) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Bioresorbable Drug-Eluting Stents 10.3 Manufacturing Process Analysis of Bioresorbable Drug-Eluting Stents 10.4 Industry Chain Structure of Bioresorbable Drug-Eluting Stents 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Bioresorbable Drug-Eluting Stents Distributors 11.3 Bioresorbable Drug-Eluting Stents Customer 12 World Forecast Review for Bioresorbable Drug-Eluting Stents by Geographic Region 12.1 Global Bioresorbable Drug-Eluting Stents Market Size Forecast by Region 12.1.1 Global Bioresorbable Drug-Eluting Stents Forecast by Region (2026-2031) 12.1.2 Global Bioresorbable Drug-Eluting Stents Annual Revenue Forecast by Region (2026-2031) 12.2 Americas Forecast by Country (2026-2031) 12.3 APAC Forecast by Region (2026-2031) 12.4 Europe Forecast by Country (2026-2031) 12.5 Middle East & Africa Forecast by Country (2026-2031) 12.6 Global Bioresorbable Drug-Eluting Stents Forecast by Type (2026-2031) 12.7 Global Bioresorbable Drug-Eluting Stents Forecast by Application (2026-2031) 13 Key Players Analysis 13.1 Abbott 13.1.1 Abbott Company Information 13.1.2 Abbott Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications 13.1.3 Abbott Bioresorbable Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2020-2025) 13.1.4 Abbott Main Business Overview 13.1.5 Abbott Latest Developments 13.2 Boston Scientific 13.2.1 Boston Scientific Company Information 13.2.2 Boston Scientific Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications 13.2.3 Boston Scientific Bioresorbable Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2020-2025) 13.2.4 Boston Scientific Main Business Overview 13.2.5 Boston Scientific Latest Developments 13.3 Biotronik 13.3.1 Biotronik Company Information 13.3.2 Biotronik Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications 13.3.3 Biotronik Bioresorbable Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2020-2025) 13.3.4 Biotronik Main Business Overview 13.3.5 Biotronik Latest Developments 13.4 Shanghai Bioheart Biological Technology 13.4.1 Shanghai Bioheart Biological Technology Company Information 13.4.2 Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications 13.4.3 Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2020-2025) 13.4.4 Shanghai Bioheart Biological Technology Main Business Overview 13.4.5 Shanghai Bioheart Biological Technology Latest Developments 13.5 LifeTech Scientific 13.5.1 LifeTech Scientific Company Information 13.5.2 LifeTech Scientific Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications 13.5.3 LifeTech Scientific Bioresorbable Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2020-2025) 13.5.4 LifeTech Scientific Main Business Overview 13.5.5 LifeTech Scientific Latest Developments 13.6 Lepu Medical Technology 13.6.1 Lepu Medical Technology Company Information 13.6.2 Lepu Medical Technology Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications 13.6.3 Lepu Medical Technology Bioresorbable Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2020-2025) 13.6.4 Lepu Medical Technology Main Business Overview 13.6.5 Lepu Medical Technology Latest Developments 13.7 Microport 13.7.1 Microport Company Information 13.7.2 Microport Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications 13.7.3 Microport Bioresorbable Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2020-2025) 13.7.4 Microport Main Business Overview 13.7.5 Microport Latest Developments 13.8 Shandong Huaan Biotechnology 13.8.1 Shandong Huaan Biotechnology Company Information 13.8.2 Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications 13.8.3 Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2020-2025) 13.8.4 Shandong Huaan Biotechnology Main Business Overview 13.8.5 Shandong Huaan Biotechnology Latest Developments 13.9 Shenzhen Salubris Biomedical Engineering 13.9.1 Shenzhen Salubris Biomedical Engineering Company Information 13.9.2 Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications 13.9.3 Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2020-2025) 13.9.4 Shenzhen Salubris Biomedical Engineering Main Business Overview 13.9.5 Shenzhen Salubris Biomedical Engineering Latest Developments 13.10 Beijing Advanced Medical Technologies 13.10.1 Beijing Advanced Medical Technologies Company Information 13.10.2 Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications 13.10.3 Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Sales, Revenue, Price and Gross Margin (2020-2025) 13.10.4 Beijing Advanced Medical Technologies Main Business Overview 13.10.5 Beijing Advanced Medical Technologies Latest Developments 14 Research Findings and Conclusion
List of Tables Table 1. Bioresorbable Drug-Eluting Stents Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions) Table 2. Bioresorbable Drug-Eluting Stents Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions) Table 3. Major Players of Metal Base Stent Table 4. Major Players of Polymer Stent Table 5. Global Bioresorbable Drug-Eluting Stents Sales by Type (2020-2025) & (K Units) Table 6. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Type (2020-2025) Table 7. Global Bioresorbable Drug-Eluting Stents Revenue by Type (2020-2025) & ($ million) Table 8. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Type (2020-2025) Table 9. Global Bioresorbable Drug-Eluting Stents Sale Price by Type (2020-2025) & (US$/Unit) Table 10. Global Bioresorbable Drug-Eluting Stents Sale by Application (2020-2025) & (K Units) Table 11. Global Bioresorbable Drug-Eluting Stents Sale Market Share by Application (2020-2025) Table 12. Global Bioresorbable Drug-Eluting Stents Revenue by Application (2020-2025) & ($ million) Table 13. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Application (2020-2025) Table 14. Global Bioresorbable Drug-Eluting Stents Sale Price by Application (2020-2025) & (US$/Unit) Table 15. Global Bioresorbable Drug-Eluting Stents Sales by Company (2020-2025) & (K Units) Table 16. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Company (2020-2025) Table 17. Global Bioresorbable Drug-Eluting Stents Revenue by Company (2020-2025) & ($ millions) Table 18. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Company (2020-2025) Table 19. Global Bioresorbable Drug-Eluting Stents Sale Price by Company (2020-2025) & (US$/Unit) Table 20. Key Manufacturers Bioresorbable Drug-Eluting Stents Producing Area Distribution and Sales Area Table 21. Players Bioresorbable Drug-Eluting Stents Products Offered Table 22. Bioresorbable Drug-Eluting Stents Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) Table 23. New Products and Potential Entrants Table 24. Market M&A Activity & Strategy Table 25. Global Bioresorbable Drug-Eluting Stents Sales by Geographic Region (2020-2025) & (K Units) Table 26. Global Bioresorbable Drug-Eluting Stents Sales Market Share Geographic Region (2020-2025) Table 27. Global Bioresorbable Drug-Eluting Stents Revenue by Geographic Region (2020-2025) & ($ millions) Table 28. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Geographic Region (2020-2025) Table 29. Global Bioresorbable Drug-Eluting Stents Sales by Country/Region (2020-2025) & (K Units) Table 30. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Country/Region (2020-2025) Table 31. Global Bioresorbable Drug-Eluting Stents Revenue by Country/Region (2020-2025) & ($ millions) Table 32. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Country/Region (2020-2025) Table 33. Americas Bioresorbable Drug-Eluting Stents Sales by Country (2020-2025) & (K Units) Table 34. Americas Bioresorbable Drug-Eluting Stents Sales Market Share by Country (2020-2025) Table 35. Americas Bioresorbable Drug-Eluting Stents Revenue by Country (2020-2025) & ($ millions) Table 36. Americas Bioresorbable Drug-Eluting Stents Sales by Type (2020-2025) & (K Units) Table 37. Americas Bioresorbable Drug-Eluting Stents Sales by Application (2020-2025) & (K Units) Table 38. APAC Bioresorbable Drug-Eluting Stents Sales by Region (2020-2025) & (K Units) Table 39. APAC Bioresorbable Drug-Eluting Stents Sales Market Share by Region (2020-2025) Table 40. APAC Bioresorbable Drug-Eluting Stents Revenue by Region (2020-2025) & ($ millions) Table 41. APAC Bioresorbable Drug-Eluting Stents Sales by Type (2020-2025) & (K Units) Table 42. APAC Bioresorbable Drug-Eluting Stents Sales by Application (2020-2025) & (K Units) Table 43. Europe Bioresorbable Drug-Eluting Stents Sales by Country (2020-2025) & (K Units) Table 44. Europe Bioresorbable Drug-Eluting Stents Revenue by Country (2020-2025) & ($ millions) Table 45. Europe Bioresorbable Drug-Eluting Stents Sales by Type (2020-2025) & (K Units) Table 46. Europe Bioresorbable Drug-Eluting Stents Sales by Application (2020-2025) & (K Units) Table 47. Middle East & Africa Bioresorbable Drug-Eluting Stents Sales by Country (2020-2025) & (K Units) Table 48. Middle East & Africa Bioresorbable Drug-Eluting Stents Revenue Market Share by Country (2020-2025) Table 49. Middle East & Africa Bioresorbable Drug-Eluting Stents Sales by Type (2020-2025) & (K Units) Table 50. Middle East & Africa Bioresorbable Drug-Eluting Stents Sales by Application (2020-2025) & (K Units) Table 51. Key Market Drivers & Growth Opportunities of Bioresorbable Drug-Eluting Stents Table 52. Key Market Challenges & Risks of Bioresorbable Drug-Eluting Stents Table 53. Key Industry Trends of Bioresorbable Drug-Eluting Stents Table 54. Bioresorbable Drug-Eluting Stents Raw Material Table 55. Key Suppliers of Raw Materials Table 56. Bioresorbable Drug-Eluting Stents Distributors List Table 57. Bioresorbable Drug-Eluting Stents Customer List Table 58. Global Bioresorbable Drug-Eluting Stents Sales Forecast by Region (2026-2031) & (K Units) Table 59. Global Bioresorbable Drug-Eluting Stents Revenue Forecast by Region (2026-2031) & ($ millions) Table 60. Americas Bioresorbable Drug-Eluting Stents Sales Forecast by Country (2026-2031) & (K Units) Table 61. Americas Bioresorbable Drug-Eluting Stents Annual Revenue Forecast by Country (2026-2031) & ($ millions) Table 62. APAC Bioresorbable Drug-Eluting Stents Sales Forecast by Region (2026-2031) & (K Units) Table 63. APAC Bioresorbable Drug-Eluting Stents Annual Revenue Forecast by Region (2026-2031) & ($ millions) Table 64. Europe Bioresorbable Drug-Eluting Stents Sales Forecast by Country (2026-2031) & (K Units) Table 65. Europe Bioresorbable Drug-Eluting Stents Revenue Forecast by Country (2026-2031) & ($ millions) Table 66. Middle East & Africa Bioresorbable Drug-Eluting Stents Sales Forecast by Country (2026-2031) & (K Units) Table 67. Middle East & Africa Bioresorbable Drug-Eluting Stents Revenue Forecast by Country (2026-2031) & ($ millions) Table 68. Global Bioresorbable Drug-Eluting Stents Sales Forecast by Type (2026-2031) & (K Units) Table 69. Global Bioresorbable Drug-Eluting Stents Revenue Forecast by Type (2026-2031) & ($ millions) Table 70. Global Bioresorbable Drug-Eluting Stents Sales Forecast by Application (2026-2031) & (K Units) Table 71. Global Bioresorbable Drug-Eluting Stents Revenue Forecast by Application (2026-2031) & ($ millions) Table 72. Abbott Basic Information, Bioresorbable Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors Table 73. Abbott Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications Table 74. Abbott Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 75. Abbott Main Business Table 76. Abbott Latest Developments Table 77. Boston Scientific Basic Information, Bioresorbable Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors Table 78. Boston Scientific Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications Table 79. Boston Scientific Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 80. Boston Scientific Main Business Table 81. Boston Scientific Latest Developments Table 82. Biotronik Basic Information, Bioresorbable Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors Table 83. Biotronik Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications Table 84. Biotronik Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 85. Biotronik Main Business Table 86. Biotronik Latest Developments Table 87. Shanghai Bioheart Biological Technology Basic Information, Bioresorbable Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors Table 88. Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications Table 89. Shanghai Bioheart Biological Technology Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 90. Shanghai Bioheart Biological Technology Main Business Table 91. Shanghai Bioheart Biological Technology Latest Developments Table 92. LifeTech Scientific Basic Information, Bioresorbable Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors Table 93. LifeTech Scientific Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications Table 94. LifeTech Scientific Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 95. LifeTech Scientific Main Business Table 96. LifeTech Scientific Latest Developments Table 97. Lepu Medical Technology Basic Information, Bioresorbable Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors Table 98. Lepu Medical Technology Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications Table 99. Lepu Medical Technology Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 100. Lepu Medical Technology Main Business Table 101. Lepu Medical Technology Latest Developments Table 102. Microport Basic Information, Bioresorbable Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors Table 103. Microport Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications Table 104. Microport Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 105. Microport Main Business Table 106. Microport Latest Developments Table 107. Shandong Huaan Biotechnology Basic Information, Bioresorbable Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors Table 108. Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications Table 109. Shandong Huaan Biotechnology Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 110. Shandong Huaan Biotechnology Main Business Table 111. Shandong Huaan Biotechnology Latest Developments Table 112. Shenzhen Salubris Biomedical Engineering Basic Information, Bioresorbable Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors Table 113. Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications Table 114. Shenzhen Salubris Biomedical Engineering Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 115. Shenzhen Salubris Biomedical Engineering Main Business Table 116. Shenzhen Salubris Biomedical Engineering Latest Developments Table 117. Beijing Advanced Medical Technologies Basic Information, Bioresorbable Drug-Eluting Stents Manufacturing Base, Sales Area and Its Competitors Table 118. Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Product Portfolios and Specifications Table 119. Beijing Advanced Medical Technologies Bioresorbable Drug-Eluting Stents Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 120. Beijing Advanced Medical Technologies Main Business Table 121. Beijing Advanced Medical Technologies Latest Developments List of Figures Figure 1. Picture of Bioresorbable Drug-Eluting Stents Figure 2. Bioresorbable Drug-Eluting Stents Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Bioresorbable Drug-Eluting Stents Sales Growth Rate 2020-2031 (K Units) Figure 7. Global Bioresorbable Drug-Eluting Stents Revenue Growth Rate 2020-2031 ($ millions) Figure 8. Bioresorbable Drug-Eluting Stents Sales by Geographic Region (2020, 2024 & 2031) & ($ millions) Figure 9. Bioresorbable Drug-Eluting Stents Sales Market Share by Country/Region (2024) Figure 10. Bioresorbable Drug-Eluting Stents Sales Market Share by Country/Region (2020, 2024 & 2031) Figure 11. Product Picture of Metal Base Stent Figure 12. Product Picture of Polymer Stent Figure 13. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Type in 2025 Figure 14. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Type (2020-2025) Figure 15. Bioresorbable Drug-Eluting Stents Consumed in Hospital Figure 16. Global Bioresorbable Drug-Eluting Stents Market: Hospital (2020-2025) & (K Units) Figure 17. Bioresorbable Drug-Eluting Stents Consumed in Specialty Clinic Figure 18. Global Bioresorbable Drug-Eluting Stents Market: Specialty Clinic (2020-2025) & (K Units) Figure 19. Global Bioresorbable Drug-Eluting Stents Sale Market Share by Application (2024) Figure 20. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Application in 2025 Figure 21. Bioresorbable Drug-Eluting Stents Sales by Company in 2025 (K Units) Figure 22. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Company in 2025 Figure 23. Bioresorbable Drug-Eluting Stents Revenue by Company in 2025 ($ millions) Figure 24. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Company in 2025 Figure 25. Global Bioresorbable Drug-Eluting Stents Sales Market Share by Geographic Region (2020-2025) Figure 26. Global Bioresorbable Drug-Eluting Stents Revenue Market Share by Geographic Region in 2025 Figure 27. Americas Bioresorbable Drug-Eluting Stents Sales 2020-2025 (K Units) Figure 28. Americas Bioresorbable Drug-Eluting Stents Revenue 2020-2025 ($ millions) Figure 29. APAC Bioresorbable Drug-Eluting Stents Sales 2020-2025 (K Units) Figure 30. APAC Bioresorbable Drug-Eluting Stents Revenue 2020-2025 ($ millions) Figure 31. Europe Bioresorbable Drug-Eluting Stents Sales 2020-2025 (K Units) Figure 32. Europe Bioresorbable Drug-Eluting Stents Revenue 2020-2025 ($ millions) Figure 33. Middle East & Africa Bioresorbable Drug-Eluting Stents Sales 2020-2025 (K Units) Figure 34. Middle East & Africa Bioresorbable Drug-Eluting Stents Revenue 2020-2025 ($ millions) Figure 35. Americas Bioresorbable Drug-Eluting Stents Sales Market Share by Country in 2025 Figure 36. Americas Bioresorbable Drug-Eluting Stents Revenue Market Share by Country (2020-2025) Figure 37. Americas Bioresorbable Drug-Eluting Stents Sales Market Share by Type (2020-2025) Figure 38. Americas Bioresorbable Drug-Eluting Stents Sales Market Share by Application (2020-2025) Figure 39. United States Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 40. Canada Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 41. Mexico Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 42. Brazil Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 43. APAC Bioresorbable Drug-Eluting Stents Sales Market Share by Region in 2025 Figure 44. APAC Bioresorbable Drug-Eluting Stents Revenue Market Share by Region (2020-2025) Figure 45. APAC Bioresorbable Drug-Eluting Stents Sales Market Share by Type (2020-2025) Figure 46. APAC Bioresorbable Drug-Eluting Stents Sales Market Share by Application (2020-2025) Figure 47. China Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 48. Japan Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 49. South Korea Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 50. Southeast Asia Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 51. India Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 52. Australia Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 53. China Taiwan Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 54. Europe Bioresorbable Drug-Eluting Stents Sales Market Share by Country in 2025 Figure 55. Europe Bioresorbable Drug-Eluting Stents Revenue Market Share by Country (2020-2025) Figure 56. Europe Bioresorbable Drug-Eluting Stents Sales Market Share by Type (2020-2025) Figure 57. Europe Bioresorbable Drug-Eluting Stents Sales Market Share by Application (2020-2025) Figure 58. Germany Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 59. France Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 60. UK Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 61. Italy Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 62. Russia Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 63. Middle East & Africa Bioresorbable Drug-Eluting Stents Sales Market Share by Country (2020-2025) Figure 64. Middle East & Africa Bioresorbable Drug-Eluting Stents Sales Market Share by Type (2020-2025) Figure 65. Middle East & Africa Bioresorbable Drug-Eluting Stents Sales Market Share by Application (2020-2025) Figure 66. Egypt Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 67. South Africa Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 68. Israel Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 69. Turkey Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 70. GCC Countries Bioresorbable Drug-Eluting Stents Revenue Growth 2020-2025 ($ millions) Figure 71. Manufacturing Cost Structure Analysis of Bioresorbable Drug-Eluting Stents in 2025 Figure 72. Manufacturing Process Analysis of Bioresorbable Drug-Eluting Stents Figure 73. Industry Chain Structure of Bioresorbable Drug-Eluting Stents Figure 74. Channels of Distribution Figure 75. Global Bioresorbable Drug-Eluting Stents Sales Market Forecast by Region (2026-2031) Figure 76. Global Bioresorbable Drug-Eluting Stents Revenue Market Share Forecast by Region (2026-2031) Figure 77. Global Bioresorbable Drug-Eluting Stents Sales Market Share Forecast by Type (2026-2031) Figure 78. Global Bioresorbable Drug-Eluting Stents Revenue Market Share Forecast by Type (2026-2031) Figure 79. Global Bioresorbable Drug-Eluting Stents Sales Market Share Forecast by Application (2026-2031) Figure 80. Global Bioresorbable Drug-Eluting Stents Revenue Market Share Forecast by Application (2026-2031)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott|||Boston Scientific|||Biotronik|||Shanghai Bioheart Biological Technology|||LifeTech Scientific|||Lepu Medical Technology|||Microport|||Shandong Huaan Biotechnology|||Shenzhen Salubris Biomedical Engineering|||Beijing Advanced Medical Technologies